183 related articles for article (PubMed ID: 17474872)
1. Androgens and estrogens in the etiology and prevention of breast cancer.
Muti P; Rogan E; Cavalieri E
Nutr Cancer; 2006; 56(2):247-52. PubMed ID: 17474872
[TBL] [Abstract][Full Text] [Related]
2. The role of endogenous hormones in the etiology and prevention of breast cancer: the epidemiological evidence.
Muti P
Ann N Y Acad Sci; 2004 Dec; 1028():273-82. PubMed ID: 15650252
[TBL] [Abstract][Full Text] [Related]
3. The role of endogenous hormones in the etiology and prevention of breast cancer: the epidemiological evidence.
Muti P
Recent Results Cancer Res; 2005; 166():245-56. PubMed ID: 15648194
[TBL] [Abstract][Full Text] [Related]
4. [Are the hereditary forms of BRCA1 and BRCA2 breast cancer sensitive to estrogens?].
Pujol P; This P; Noruzinia M; Stoppa-Lyonnet D; Maudelonde T
Bull Cancer; 2004; 91(7-8):583-91. PubMed ID: 15381448
[TBL] [Abstract][Full Text] [Related]
5. Estrogens, BRCA1, and breast cancer.
Hilakivi-Clarke L
Cancer Res; 2000 Sep; 60(18):4993-5001. PubMed ID: 11016617
[TBL] [Abstract][Full Text] [Related]
6. Is BRCA1/BRCA2-related breast carcinogenesis estrogen dependent?
Noruzinia M; Coupier I; Pujol P
Cancer; 2005 Oct; 104(8):1567-74. PubMed ID: 16155942
[TBL] [Abstract][Full Text] [Related]
7. [Breast cancer genetics. BRCA1 and BRCA2: the main genes for disease predisposition].
Ruiz-Flores P; Calderón-Garcidueñas AL; Barrera-Saldaña HA
Rev Invest Clin; 2001; 53(1):46-64. PubMed ID: 11332051
[TBL] [Abstract][Full Text] [Related]
8. Incidence of BRCA1 and BRCA2 mutations in 54 Chilean families with breast/ovarian cancer, genotype-phenotype correlations.
Gallardo M; Silva A; Rubio L; Alvarez C; Torrealba C; Salinas M; Tapia T; Faundez P; Palma L; Riccio ME; Paredes H; Rodriguez M; Cruz A; Rousseau C; King MC; Camus M; Alvarez M; Carvallo P
Breast Cancer Res Treat; 2006 Jan; 95(1):81-7. PubMed ID: 16261400
[TBL] [Abstract][Full Text] [Related]
9. Considerations in genetic counseling for inherited breast cancer predisposition.
Robson ME; Offit K
Semin Radiat Oncol; 2002 Oct; 12(4):362-70. PubMed ID: 12382194
[TBL] [Abstract][Full Text] [Related]
10. Use of expression data and the CGEMS genome-wide breast cancer association study to identify genes that may modify risk in BRCA1/2 mutation carriers.
Walker LC; Waddell N; Ten Haaf A; ; Grimmond S; Spurdle AB
Breast Cancer Res Treat; 2008 Nov; 112(2):229-36. PubMed ID: 18095154
[TBL] [Abstract][Full Text] [Related]
11. Models of genetic susceptibility to breast cancer.
Antoniou AC; Easton DF
Oncogene; 2006 Sep; 25(43):5898-905. PubMed ID: 16998504
[TBL] [Abstract][Full Text] [Related]
12. Breast-feeding and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers.
Jernström H; Lubinski J; Lynch HT; Ghadirian P; Neuhausen S; Isaacs C; Weber BL; Horsman D; Rosen B; Foulkes WD; Friedman E; Gershoni-Baruch R; Ainsworth P; Daly M; Garber J; Olsson H; Sun P; Narod SA
J Natl Cancer Inst; 2004 Jul; 96(14):1094-8. PubMed ID: 15265971
[TBL] [Abstract][Full Text] [Related]
13. Can genetic testing guide treatment in breast cancer?
Tutt A; Ashworth A
Eur J Cancer; 2008 Dec; 44(18):2774-80. PubMed ID: 19027287
[TBL] [Abstract][Full Text] [Related]
14. Molecular analysis of the BRCA1 and BRCA2 genes in 32 breast and/or ovarian cancer Spanish families.
Osorio A; Barroso A; Martínez B; Cebrián A; San Román JM; Lobo F; Robledo M; Benítez J
Br J Cancer; 2000 Apr; 82(7):1266-70. PubMed ID: 10755399
[TBL] [Abstract][Full Text] [Related]
15. Missense polymorphisms in BRCA1 and BRCA2 and risk of breast and ovarian cancer.
Dombernowsky SL; Weischer M; Freiberg JJ; Bojesen SE; Tybjaerg-Hansen A; Nordestgaard BG
Cancer Epidemiol Biomarkers Prev; 2009 Aug; 18(8):2339-42. PubMed ID: 19661094
[TBL] [Abstract][Full Text] [Related]
16. The prevention of hereditary breast cancer.
Rodriquez E; Domchek SM
Semin Oncol; 2007 Oct; 34(5):401-5. PubMed ID: 17920894
[TBL] [Abstract][Full Text] [Related]
17. [Review of risk factors for breast cancer--what's new?].
Haimov-Kochman R; Lavy Y; Hochner-Celinkier D
Harefuah; 2002 Aug; 141(8):702-8, 761. PubMed ID: 12222134
[TBL] [Abstract][Full Text] [Related]
18. Infertility, treatment of infertility, and the risk of breast cancer among women with BRCA1 and BRCA2 mutations: a case-control study.
Kotsopoulos J; Librach CL; Lubinski J; Gronwald J; Kim-Sing C; Ghadirian P; Lynch HT; Moller P; Foulkes WD; Randall S; Manoukian S; Pasini B; Tung N; Ainsworth PJ; Cummings S; Sun P; Narod SA;
Cancer Causes Control; 2008 Dec; 19(10):1111-9. PubMed ID: 18509731
[TBL] [Abstract][Full Text] [Related]
19. [BRCA1 and BRCA2 have reached the clinical medicine. The 10-year old finding of the genetic mutation makes it now possible to prevent breast cancer].
Loman N
Lakartidningen; 2004 Jun; 101(25):2172-7. PubMed ID: 15281304
[TBL] [Abstract][Full Text] [Related]
20. The risk of ovarian cancer after breast cancer in BRCA1 and BRCA2 carriers.
Metcalfe KA; Lynch HT; Ghadirian P; Tung N; Olivotto IA; Foulkes WD; Warner E; Olopade O; Eisen A; Weber B; McLennan J; Sun P; Narod SA
Gynecol Oncol; 2005 Jan; 96(1):222-6. PubMed ID: 15589605
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
